DOCSLIB.ORG

Architecture of the Human XPC DNA Repair and Stem Cell Coactivator Complex

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Architecture of the Human XPC DNA Repair and Stem Cell Coactivator Complex Architecture of the human XPC DNA repair and stem cell coactivator complex Elisa T. Zhanga,b,c, Yuan Hed,1, Patricia Groba,b, Yick W. Fonga,b,2, Eva Nogalesa,b,d, and Robert Tjiana,b,c,e,3 aDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720; bHoward Hughes Medical Institute, Department of Molecular and Cell Biology, University of California, Berkeley, CA 94720; cLi Ka Shing Center for Biomedical and Health Sciences, CIRM Center of Excellence, University of California Berkeley, CA 94720; dLife Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94710; and eHoward Hughes Medical Institute, Chevy Chase, MD 20815-6789 Contributed by Robert Tjian, October 16, 2015 (sent for review August 20, 2015; reviewed by Montserrat Samso and Ning Zheng) The Xeroderma pigmentosum complementation group C (XPC) involved in base excision repair (BER). BER is responsible for complex is a versatile factor involved in both nucleotide excision removing primarily non-helix-distorting lesions from the ge- repair and transcriptional coactivation as a critical component of nome (2). In BER, the XPC complex helps repair oxidative the NANOG, OCT4, and SOX2 pluripotency gene regulatory net- damage by stimulating the activities of DNA glycosylases such work. Here we present the structure of the human holo-XPC com- as OGG1 and TDG (3) to target lesions including 8-oxoguanine, plex determined by single-particle electron microscopy to reveal a independently of other downstream GG-NER factors (17). flexible, ear-shaped structure that undergoes localized loss of order More recently, the XPC complex has also been found to upon DNA binding. We also determined the structure of the complete perform crucial duties in the regulation of gene transcription, the yeast homolog Rad4 holo-complex to find a similar overall architec- second primary function of the genome. In embryonic stem cells ture to the human complex, consistent with their shared DNA repair (ESCs), the XPC complex acts as a coactivator to enhance the functions. Localized differences between these structures reflect an expression of OCT4- and SOX2-driven pluripotency genes, most intriguing phylogenetic divergence in transcriptional capabilities that notably NANOG (4), buttressing the gene regulatory network we present here. Having positioned the constituent subunits by tag- that establishes and maintains the unique self-renewal and plu- ging and deletion, we propose a model of key interaction interfaces ripotency properties of ESCs. The XPC complex performs its that reveals the structural basis for this difference in functional con- BIOCHEMISTRY servation. Together, our findings establish a framework for under- coactivator functions independently of DNA binding (4, 18), standing the structure-function relationships of the XPC complex in presumably by bridging interactions between the sequence-spe- the interplay between transcription and DNA repair. cific transcription factors OCT4 (octamer-binding transcrip- tion factor 4; also known as POU5F1) and SOX2 [SRY (sex- transcription | stem cells | DNA repair | structure | biochemistry determining region Y)-box 2] and the general transcriptional machinery, such as TFIID and RNA pol II, thus following a enomes of living organisms serve two primary functions: as mechanism reminiscent of that of other coactivator complexes Gvehicles for hereditary information and as the template for gene products involved in an organism’s development and re- Significance sponses to environmental stimuli. Vital to maintaining the health of genomes in the face of intrinsic and extrinsic sources of DNA Embryonic or pluripotent stem cells are unique in their ability to damage are a suite of DNA repair pathways, each dedicated to self-renew in culture and to generate all lineages of an adult or- handling specific lesions. Similarly, proper use and expression of ganism, making them valuable tools for modeling early de- this essential genomic information is regulated by a host of tran- velopmental processes and for developing regenerative medicine scription factors, chromatin remodelers, and epigenetic modifiers technologies. An important factor in controlling the expression of and readers (1). The Xeroderma pigmentosum complementation pluripotency genes is the Xeroderma pigmentosum complemen- group C (XPC) protein complex performs crucial roles in both tation group C (XPC) DNA repair complex. This study presents, to of these capacities by participating in nucleotide excision repair our knowledge, the first complete structures of different XPC complexes by electron microscopy to establish an important (NER) (2) and base excision repair (BER) (3), as well as transcrip- ’ tional regulation (4) and other processes (5). framework for a molecular understanding of XPC stwoprimary The XPC complex is one of seven XP complementation groups functions. In conjunction with our biochemical findings, we syn- thesize a model of how XPC performs both its evolutionarily A–G and is composed of the 125-kDa XPC, the 58-kDa RAD23B conserved DNA repair function and its evolutionarily noncon- (Rad23 homolog B; also known as HHR23B), and the 18-kDa served transcription function. CETN2 (Centrin2) subunits (2). RAD23B and CETN2 associate – tightly with XPC and stabilize both its DNA repair (6 10) and Author contributions: E.T.Z., E.N., and R.T. designed research; E.T.Z., Y.H., and Y.W.F. stem cell coactivator functions (4). The XPC complex is the ini- performed research; E.T.Z. and Y.W.F. contributed new reagents/analytic tools; E.T.Z., tiator and main DNA damage sensor in global genome nucleotide Y.H., P.G., and Y.W.F. analyzed data; and E.T.Z., E.N., and R.T. wrote the paper. excision repair (GG-NER), one of two branches of the nucleotide Reviewers: M.S., Virginia Commonwealth University; and N.Z., University of Washington. excision repair pathway that repairs a wide array of bulky, helix- The authors declare no conflict of interest. distorting lesions (2, 11); the second form of NER or transcrip- Data deposition: Atomic coordinates and structure factors have been deposited in the tion-coupled repair (TC-NER) targets lesions blocking tran- Electron Microscopy Data Bank (EMDB), https://www.ebi.ac.uk/pdbe/emdb/ (accession scription to reactivate proper gene expression (2, 12). Defects nos. EMD-6495–EMD-6498). 1 in GG-NER lead to photosensitivity and a predisposition to cer- Present address: Department of Molecular Biosciences, Northwestern University, Evanston, IL 60208. tain cancers in animal models and in human patients with Xero- 2Present address: Brigham Regenerative Medicine Center, Cardiovascular Division, De- derma pigmentosum (13). In conjunction with the UV-damage partment of Medicine Brigham and Women’s Hospital, Harvard Medical School, Cam- DNA-binding protein (UV-DDB) (2, 12), the XPC complex bridge, MA 02139. recruits >30 downstream factors, such as XPA (14), TFIIH (15, 3To whom correspondence should be addressed. Email: [email protected]. 16), and the endonucleases XPF and XPG to remove these ad- This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. ducts (2, 11). In addition to its role in GG-NER, XPC is also 1073/pnas.1520104112/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1520104112 PNAS Early Edition | 1of6 Downloaded by guest on September 25, 2021 such as Mediator and p300/CBP (19). In a separate study, XPC TFIIH-BD1 DNA-BD A 124 144 607 742 was found to localize to active but not to inactive RNA pol II- XPA- & OGG1-BD OCT4-BD SOX2-BD 1 154 331 511 808 940 dependent gene promoters in the absence of exogenous geno- XPC TGD TGD BH1 BH2 BH3 204 223 496 734 814 toxic stress (11, 20). RAD23B-BD2 TFIIH-BD2 RAD23B-BD1 847 863 Although both the DNA repair and transcriptional functions 1 276 334 419 CETN2-BD RAD23B UbL of mammalian XPC complexes have been characterized bio- UBA1 XPC-BD UBA2 chemically and genetically, 3D structural information of the 1 172 CETN2 EF EF holo-complex has been unavailable. The partial crystal structure 105 166 XPC-BD of Rad4, the yeast homolog of the human XPC subunit, in B D R C complex with the Rad4-interaction domain of yeast Rad23, has XPC provided information helpful toward an understanding of Rad4/ XPC’s biochemical behavior and of certain phenotypic outcomes 180° 180° ’ (18, 21). However, given XPC s low sequence homology with the 170 Å yeast homolog Rad4 (21, 22), the absence of key domains in the available crystal structure, and the divergence of requirements for transcriptional vs. repair activities (4, 15, 18, 23), structural in- 100 Å formation of the complete, three-subunit, native human XPC R MBP C C E complex is much needed for an understanding of the functional XPC versatility of the XPC complex. At present, no information has 180° been reported on the overall architecture of the XPC holo- 180° complex, the possible large-scale conformational rearrangements UbL in XPC upon DNA-binding, or the extent of structural conser- UBA1 vation of the human XPC complex with homolog complexes. UBA2 Here we address the lack of structural data on human XPC using 3D single-particle reconstruction by electron microscopy Fig. 1. 3D reconstruction of the human XPC complex and localization of (EM) to characterize the overall architecture of XPC, as well as subunits. (A) Schematic representation of the subunits and domains of the genetic tagging and computational docking to locate the relative human XPC complex. Transglutaminase homology domain (TGD), β-hairpin positions of its constituent subunits. We also assess the confor- domains 1–3 (BH), ubiquitin-like domain (UbL), ubiquitin-associated domains 1 mational changes to the complex upon binding to DNA. Given and 2 (UBA), EF-hand domains (EF), and protein- and DNA-binding domains the evolutionary conservation of GG-NER (24), we queried the (BD) are indicated accordingly. (B) Front and back views of the XPC complex extent of structural and functional conservation over evolution- reconstructed in EMAN2 (49).
Load more

Recommended publications
  • Variant Requirements for DNA Repair Proteins in Cancer Cell Lines That Use
    Variant requirements for DNA repair proteins in cancer cell lines that use alternative lengthening of telomere mechanisms of elongation DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Alaina Rae Martinez Biomedical Sciences Graduate Program The Ohio State University 2016 Dissertation Committee: Dr. Jeffrey D. Parvin, Advisor Dr. Joanna Groden Dr. Amanda E. Toland Dr. Kay F. Huebner Copyright by Alaina Rae Martinez 2016 Abstract The human genome relies on DNA repair proteins and the telomere to maintain genome stability. Genome instability is recognized as a hallmark of cancer, as is limitless replicative capacity. Cancer cells require telomere maintenance to enable this uncontrolled growth. Most often telomerase is activated, although a subset of human cancers depend on recombination-based mechanisms known as Alternative Lengthening of Telomeres (ALT). ALT depends invariably on recombination and its associated DNA repair proteins to extend telomeres. This study tested the hypothesis that the requirement for those requisite recombination proteins include other types of DNA repair proteins. These functions were tested in ALT cell lines using C-circle abundance as a marker of ALT. The requirement for homologous recombination proteins and other DNA repair proteins varied between ALT cell lines compared. Several proteins essential for homologous recombination were dispensable for C-circle production in some ALT cell lines, while proteins grouped into excision DNA repair processes were required for C- circle production. The MSH2 mismatch repair protein was required for telomere recombination by intertelomeric exchange. In sum, our study suggests that ALT proceeds by multiple mechanisms that differ between human cancer cell lines and that some of these depend on DNA repair proteins not associated with homologous recombination pathways.
    [Show full text]
  • Structure and Function of the Human Recq DNA Helicases
    Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2005 Structure and function of the human RecQ DNA helicases Garcia, P L Posted at the Zurich Open Repository and Archive, University of Zurich ZORA URL: https://doi.org/10.5167/uzh-34420 Dissertation Published Version Originally published at: Garcia, P L. Structure and function of the human RecQ DNA helicases. 2005, University of Zurich, Faculty of Science. Structure and Function of the Human RecQ DNA Helicases Dissertation zur Erlangung der naturwissenschaftlichen Doktorw¨urde (Dr. sc. nat.) vorgelegt der Mathematisch-naturwissenschaftlichen Fakultat¨ der Universitat¨ Z ¨urich von Patrick L. Garcia aus Unterseen BE Promotionskomitee Prof. Dr. Josef Jiricny (Vorsitz) Prof. Dr. Ulrich H ¨ubscher Dr. Pavel Janscak (Leitung der Dissertation) Z ¨urich, 2005 For my parents ii Summary The RecQ DNA helicases are highly conserved from bacteria to man and are required for the maintenance of genomic stability. All unicellular organisms contain a single RecQ helicase, whereas the number of RecQ homologues in higher organisms can vary. Mu- tations in the genes encoding three of the five human members of the RecQ family give rise to autosomal recessive disorders called Bloom syndrome, Werner syndrome and Rothmund-Thomson syndrome. These diseases manifest commonly with genomic in- stability and a high predisposition to cancer. However, the genetic alterations vary as well as the types of tumours in these syndromes. Furthermore, distinct clinical features are observed, like short stature and immunodeficiency in Bloom syndrome patients or premature ageing in Werner Syndrome patients. Also, the biochemical features of the human RecQ-like DNA helicases are diverse, pointing to different roles in the mainte- nance of genomic stability.
    [Show full text]
  • Open Full Page
    CCR PEDIATRIC ONCOLOGY SERIES CCR Pediatric Oncology Series Recommendations for Childhood Cancer Screening and Surveillance in DNA Repair Disorders Michael F. Walsh1, Vivian Y. Chang2, Wendy K. Kohlmann3, Hamish S. Scott4, Christopher Cunniff5, Franck Bourdeaut6, Jan J. Molenaar7, Christopher C. Porter8, John T. Sandlund9, Sharon E. Plon10, Lisa L. Wang10, and Sharon A. Savage11 Abstract DNA repair syndromes are heterogeneous disorders caused by around the world to discuss and develop cancer surveillance pathogenic variants in genes encoding proteins key in DNA guidelines for children with cancer-prone disorders. Herein, replication and/or the cellular response to DNA damage. The we focus on the more common of the rare DNA repair dis- majority of these syndromes are inherited in an autosomal- orders: ataxia telangiectasia, Bloom syndrome, Fanconi ane- recessive manner, but autosomal-dominant and X-linked reces- mia, dyskeratosis congenita, Nijmegen breakage syndrome, sive disorders also exist. The clinical features of patients with DNA Rothmund–Thomson syndrome, and Xeroderma pigmento- repair syndromes are highly varied and dependent on the under- sum. Dedicated syndrome registries and a combination of lying genetic cause. Notably, all patients have elevated risks of basic science and clinical research have led to important in- syndrome-associated cancers, and many of these cancers present sights into the underlying biology of these disorders. Given the in childhood. Although it is clear that the risk of cancer is rarity of these disorders, it is recommended that centralized increased, there are limited data defining the true incidence of centers of excellence be involved directly or through consulta- cancer and almost no evidence-based approaches to cancer tion in caring for patients with heritable DNA repair syn- surveillance in patients with DNA repair disorders.
    [Show full text]
  • Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-Like Mouse Models: Tracking the Role of the Hairless Gene
    University of Tennessee, Knoxville TRACE: Tennessee Research and Creative Exchange Doctoral Dissertations Graduate School 5-2006 Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-like Mouse Models: Tracking the Role of the Hairless Gene Yutao Liu University of Tennessee - Knoxville Follow this and additional works at: https://trace.tennessee.edu/utk_graddiss Part of the Life Sciences Commons Recommended Citation Liu, Yutao, "Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino- like Mouse Models: Tracking the Role of the Hairless Gene. " PhD diss., University of Tennessee, 2006. https://trace.tennessee.edu/utk_graddiss/1824 This Dissertation is brought to you for free and open access by the Graduate School at TRACE: Tennessee Research and Creative Exchange. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of TRACE: Tennessee Research and Creative Exchange. For more information, please contact [email protected]. To the Graduate Council: I am submitting herewith a dissertation written by Yutao Liu entitled "Molecular and Physiological Basis for Hair Loss in Near Naked Hairless and Oak Ridge Rhino-like Mouse Models: Tracking the Role of the Hairless Gene." I have examined the final electronic copy of this dissertation for form and content and recommend that it be accepted in partial fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in Life Sciences. Brynn H. Voy, Major Professor We have read this dissertation and recommend its acceptance: Naima Moustaid-Moussa, Yisong Wang, Rogert Hettich Accepted for the Council: Carolyn R.
    [Show full text]
  • Identification of Novel Pathogenic MSH2 Mutation and New DNA Repair Genes Variants: Investigation of a Tunisian Lynch Syndrome F
    Jaballah‑Gabteni et al. J Transl Med (2019) 17:212 https://doi.org/10.1186/s12967‑019‑1961‑9 Journal of Translational Medicine RESEARCH Open Access Identifcation of novel pathogenic MSH2 mutation and new DNA repair genes variants: investigation of a Tunisian Lynch syndrome family with discordant twins Amira Jaballah‑Gabteni1,3* , Haifa Tounsi1,3, Maria Kabbage1,3, Yosr Hamdi3, Sahar Elouej3,4, Ines Ben Ayed1,3, Mouna Medhioub2, Moufda Mahmoudi2, Hamza Dallali3, Hamza Yaiche1,3, Nadia Ben Jemii1,3, Affa Maaloul1, Najla Mezghani1,3, Sonia Abdelhak3, Lamine Hamzaoui2, Mousaddak Azzouz2 and Samir Boubaker1,3 Abstract Background: Lynch syndrome (LS) is a highly penetrant inherited cancer predisposition syndrome, characterized by autosomal dominant inheritance and germline mutations in DNA mismatch repair genes. Despite several genetic variations that have been identifed in various populations, the penetrance is highly variable and the reasons for this have not been fully elucidated. This study investigates whether, besides pathogenic mutations, environment and low penetrance genetic risk factors may result in phenotype modifcation in a Tunisian LS family. Patients and methods: A Tunisian family with strong colorectal cancer (CRC) history that fulfll the Amsterdam I criteria for the diagnosis of Lynch syndrome was proposed for oncogenetic counseling. The index case was a man, diagnosed at the age of 33 years with CRC. He has a monozygotic twin diagnosed at the age of 35 years with crohn disease. Forty‑seven years‑old was the onset age of his paternal uncle withCRC. An immunohistochemical (IHC) labe‑ ling for the four proteins (MLH1, MSH2, MSH6 and PMS2) of the MisMatchRepair (MMR) system was performed for the index case.
    [Show full text]
  • Dissertation Submitted to the Combined Faculties for the Natural Sciences and for Mathematics of the Ruperto-Carola University O
    Dissertation submitted to the Combined Faculties for the Natural Sciences and for Mathematics of the Ruperto-Carola University of Heidelberg, Germany For the degree of Doctor of Natural Sciences Presented by M.Phil - Rashda Abbasi Born in Karachi, Pakistan Oral-examination:…………………………… I II Nucleotide excision repair pathway modulating both cancer risk and therapy Referees: Prof. Dr. Thomas Efferth PD Dr. Rajiv Kumar III IV Division: Epigenomics and Cancer Risk Factors Head of the division: Prof. Dr. Christoph Plass Deutsches Krebsforschungszentrum (DKFZ) in the Helmholtz Association Heidelberg V VI DECLARATION This thesis is a presentation of my original research work and that it has not been submitted anywhere for any award. Wherever contributions of others are involved, every effort is made to indicate this clearly, with due reference to the literature. Heidelberg, 1st December, 2009 Rashda Abbasi VII VIII In The Name Of Allah, The Most Beneficent, The Most Merciful IX X Summary Summary Nucleotide excision repair (NER) plays a key role in repairing a wide variety of DNA damage including bulky DNA adducts caused by ultraviolet radiation and exposure to harmful substances like tobacco smoke and alcohol. Genetic variations and somatic mutations in NER genes might affect cancer risk and therapy. However, both these aspects are not well understood. The first part of the thesis deals with the role of NER in modulation of laryngeal cancer risk. The major risk factors for laryngeal cancer are smoking and high alcohol consumption. Polymorphisms in NER genes might therefore affect laryngeal cancer susceptibility. In a population-based case-control study including 248 cases and 647 controls, the association of laryngeal cancer with 11 single nucleotide polymorphisms (SNPs) in 7 NER genes (XPC, ERCC1, ERCC2, ERCC4, ERCC5, ERCC6 and RAD23B) was analyzed with respect to smoking and alcohol exposure.
    [Show full text]
  • Cep57, a NEDD1-Binding Pericentriolar Material Component, Is Essential for Spindle Pole Integrity
    Cell Research (2012) :1-12. © 2012 IBCB, SIBS, CAS All rights reserved 1001-0602/12 $ 32.00 npg ORIGINAL ARTICLE www.nature.com/cr Cep57, a NEDD1-binding pericentriolar material component, is essential for spindle pole integrity Qixi Wu1, *, Runsheng He1, *, Haining Zhou1, Albert CH Yu2, Bo Zhang1, Junlin Teng1, Jianguo Chen1, 3 1The State Key Laboratory of Biomembrane and Membrane Bioengineering and The Key Laboratory of Cell Proliferation and Dif- ferentiation of Ministry of Education, College of Life Sciences, Peking University, Beijing 100871, China; 2Department of Neurobi- ology, Neuroscience Research Institute, School of Basic Medical Sciences, Peking University, Beijing 100191, China; 3The Center for Theoretical Biology, Peking University, Beijing 100871, China Formation of a bipolar spindle is indispensable for faithful chromosome segregation and cell division. Spindle in- tegrity is largely dependent on the centrosome and the microtubule network. Centrosome protein Cep57 can bundle microtubules in mammalian cells. Its related protein (Cep57R) in Xenopus was characterized as a stabilization factor for microtubule-kinetochore attachment. Here we show that Cep57 is a pericentriolar material (PCM) component. Its interaction with NEDD1 is necessary for the centrosome localization of Cep57. Depletion of Cep57 leads to unaligned chromosomes and a multipolar spindle, which is induced by PCM fragmentation. In the absence of Cep57, cen- trosome microtubule array assembly activity is weakened, and the spindle length and microtubule density decrease. As a spindle microtubule-binding protein, Cep57 is also responsible for the proper organization of the spindle micro- tubule and localization of spindle pole focusing proteins. Collectively, these results suggest that Cep57, as a NEDD1- binding centrosome component, could function as a spindle pole- and microtubule-stabilizing factor for establishing robust spindle architecture.
    [Show full text]
  • Evidence for Premature Aging Due to Oxidative Stress in Ipscs from Cockayne Syndrome
    Human Molecular Genetics, 2012, Vol. 21, No. 17 3825–3834 doi:10.1093/hmg/dds211 Advance Access published on June 1, 2012 Evidence for premature aging due to oxidative stress in iPSCs from Cockayne syndrome Luciana Nogueira de Sousa Andrade1,2,3, Jason L. Nathanson2, Gene W. Yeo2, Carlos Frederico Martins Menck3 and Alysson Renato Muotri1,2,∗ 1School of Medicine, Department of Pediatrics/Rady Children’s Hospital San Diego and 2Department of Cellular & Molecular Medicine, University of California San Diego, Stem Cell Program, 2880 Torrey Pines Scenic Road - Sanford Consortium, La Jolla, CA 92093, MC 0695, USA and 3Department of Microbiology, DNA Repair Laboratory, Downloaded from Biomedical Institute, University of Sa˜o Paulo, 1374 Av. Prof. Lineu Prestes, Sa˜o Paulo, SP 05508-000, Brazil Received March 28, 2012; Revised May 18, 2012; Accepted May 28, 2012 Cockayne syndrome (CS) is a human premature aging disorder associated with neurological and develop- http://hmg.oxfordjournals.org/ mental abnormalities, caused by mutations mainly in the CS group B gene (ERCC6). At the molecular level, CS is characterized by a deficiency in the transcription-couple DNA repair pathway. To understand the role of this molecular pathway in a pluripotent cell and the impact of CSB mutation during human cellular development, we generated induced pluripotent stem cells (iPSCs) from CSB skin fibroblasts (CSB-iPSC). Here, we showed that the lack of functional CSB does not represent a barrier to genetic reprogramming. However, iPSCs derived from CSB patient’s fibroblasts exhibited elevated cell death rate and higher reactive oxygen species (ROS) production. Moreover, these cellular phenotypes were accompanied by an up-regulation of TXNIP and TP53 transcriptional expression.
    [Show full text]
  • Supplemental Information
    Supplemental information Dissection of the genomic structure of the miR-183/96/182 gene. Previously, we showed that the miR-183/96/182 cluster is an intergenic miRNA cluster, located in a ~60-kb interval between the genes encoding nuclear respiratory factor-1 (Nrf1) and ubiquitin-conjugating enzyme E2H (Ube2h) on mouse chr6qA3.3 (1). To start to uncover the genomic structure of the miR- 183/96/182 gene, we first studied genomic features around miR-183/96/182 in the UCSC genome browser (http://genome.UCSC.edu/), and identified two CpG islands 3.4-6.5 kb 5’ of pre-miR-183, the most 5’ miRNA of the cluster (Fig. 1A; Fig. S1 and Seq. S1). A cDNA clone, AK044220, located at 3.2-4.6 kb 5’ to pre-miR-183, encompasses the second CpG island (Fig. 1A; Fig. S1). We hypothesized that this cDNA clone was derived from 5’ exon(s) of the primary transcript of the miR-183/96/182 gene, as CpG islands are often associated with promoters (2). Supporting this hypothesis, multiple expressed sequences detected by gene-trap clones, including clone D016D06 (3, 4), were co-localized with the cDNA clone AK044220 (Fig. 1A; Fig. S1). Clone D016D06, deposited by the German GeneTrap Consortium (GGTC) (http://tikus.gsf.de) (3, 4), was derived from insertion of a retroviral construct, rFlpROSAβgeo in 129S2 ES cells (Fig. 1A and C). The rFlpROSAβgeo construct carries a promoterless reporter gene, the β−geo cassette - an in-frame fusion of the β-galactosidase and neomycin resistance (Neor) gene (5), with a splicing acceptor (SA) immediately upstream, and a polyA signal downstream of the β−geo cassette (Fig.
    [Show full text]
  • Arsenic Disruption of DNA Damage Responses—Potential Role in Carcinogenesis and Chemotherapy
    Biomolecules 2015, 5, 2184-2193; doi:10.3390/biom5042184 OPEN ACCESS biomolecules ISSN 2218-273X www.mdpi.com/journal/biomolecules/ Review Arsenic Disruption of DNA Damage Responses—Potential Role in Carcinogenesis and Chemotherapy Clarisse S. Muenyi 1, Mats Ljungman 2 and J. Christopher States 3,* 1 Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40292, USA; E-Mail: [email protected] 2 Departments of Radiation Oncology and Environmental Health Sciences, University of Michigan, Ann Arbor, MI 48109-2800, USA; E-Mail: [email protected] 3 Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40292, USA * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-502-852-5347; Fax: +1-502-852-3123. Academic Editors: Wolf-Dietrich Heyer, Thomas Helleday and Fumio Hanaoka Received: 14 August 2015 / Accepted: 9 September 2015 / Published: 24 September 2015 Abstract: Arsenic is a Class I human carcinogen and is widespread in the environment. Chronic arsenic exposure causes cancer in skin, lung and bladder, as well as in other organs. Paradoxically, arsenic also is a potent chemotherapeutic against acute promyelocytic leukemia and can potentiate the cytotoxic effects of DNA damaging chemotherapeutics, such as cisplatin, in vitro. Arsenic has long been implicated in DNA repair inhibition, cell cycle disruption, and ubiquitination dysregulation, all negatively impacting the DNA damage response and potentially contributing to both the carcinogenic and chemotherapeutic potential of arsenic. Recent studies have provided mechanistic insights into how arsenic interferes with these processes including disruption of zinc fingers and suppression of gene expression.
    [Show full text]
  • An ERCC4 Regulatory Variant Predicts Grade‐
    IJC International Journal of Cancer An ERCC4 regulatory variant predicts grade-3 or -4 toxicities in patients with advanced non-small cell lung cancer treated by platinum-based therapy Ruoxin Zhang1, Ming Jia1,2, Yuan Xu1,2, Danwen Qian1,2, Mengyun Wang1, Meiling Zhu3, Menghong Sun1,4, Jianhua Chang1,5 and Qingyi Wei 1,2,6 1 Cancer Institute, Collaborative Innovative Center for Cancer Medicine, Fudan University Shanghai Cancer Center, 270 Dong An Road, Xuhui District, Shanghai, 200032, People’s Republic of China 2 Department of Oncology, Shanghai Medical College, Fudan University Shanghai Cancer Center, 270 Dong An Road, Shanghai, 200032, People’s Republic of China 3 Department of Oncology, Xinhua Hospital affiliated to Shanghai Jiaotong University, No. 1665 Kong Jiang Road, Shanghai, 200092, People’s Republic of China 4 Department of Pathology, Fudan University Shanghai Cancer Center, 270 Dong An Road, Shanghai, 200032, People’s Republic of China 5 Department of Medical Oncology, Fudan University Shanghai Cancer Center, 270 Dong An Road, Shanghai, 200032, People’s Republic of China 6 Duke Cancer Institute, Duke University Medical Center, 10 Bryn Searle Dr., Durham, NC 27710, USA Platinum-based chemotherapy (PBC) in combination with the 3rd generation drugs is the first-line treatment for patients with advanced non-small cell lung cancer (NSCLC); however, the efficacy is severely hampered by grade 3–4 toxicities. Nucleotide excision repair (NER) pathway is the main mechanism of removing platinum-induced DNA adducts that contribute to the toxic- Cancer Epidemiology ity and outcome of PBC. We analyzed data from 710 Chinese NSCLC patients treated with PBC and assessed the associations of 25 potentially functional single nucleotide polymorphisms (SNPs) in nine NER core genes with overall, gastrointestinal and hematologic toxicities.
    [Show full text]
  • Table S2.Up Or Down Regulated Genes in Tcof1 Knockdown Neuroblastoma N1E-115 Cells Involved in Differentbiological Process Anal
    Table S2.Up or down regulated genes in Tcof1 knockdown neuroblastoma N1E-115 cells involved in differentbiological process analysed by DAVID database Pop Pop Fold Term PValue Genes Bonferroni Benjamini FDR Hits Total Enrichment GO:0044257~cellular protein catabolic 2.77E-10 MKRN1, PPP2R5C, VPRBP, MYLIP, CDC16, ERLEC1, MKRN2, CUL3, 537 13588 1.944851 8.64E-07 8.64E-07 5.02E-07 process ISG15, ATG7, PSENEN, LOC100046898, CDCA3, ANAPC1, ANAPC2, ANAPC5, SOCS3, ENC1, SOCS4, ASB8, DCUN1D1, PSMA6, SIAH1A, TRIM32, RNF138, GM12396, RNF20, USP17L5, FBXO11, RAD23B, NEDD8, UBE2V2, RFFL, CDC GO:0051603~proteolysis involved in 4.52E-10 MKRN1, PPP2R5C, VPRBP, MYLIP, CDC16, ERLEC1, MKRN2, CUL3, 534 13588 1.93519 1.41E-06 7.04E-07 8.18E-07 cellular protein catabolic process ISG15, ATG7, PSENEN, LOC100046898, CDCA3, ANAPC1, ANAPC2, ANAPC5, SOCS3, ENC1, SOCS4, ASB8, DCUN1D1, PSMA6, SIAH1A, TRIM32, RNF138, GM12396, RNF20, USP17L5, FBXO11, RAD23B, NEDD8, UBE2V2, RFFL, CDC GO:0044265~cellular macromolecule 6.09E-10 MKRN1, PPP2R5C, VPRBP, MYLIP, CDC16, ERLEC1, MKRN2, CUL3, 609 13588 1.859332 1.90E-06 6.32E-07 1.10E-06 catabolic process ISG15, RBM8A, ATG7, LOC100046898, PSENEN, CDCA3, ANAPC1, ANAPC2, ANAPC5, SOCS3, ENC1, SOCS4, ASB8, DCUN1D1, PSMA6, SIAH1A, TRIM32, RNF138, GM12396, RNF20, XRN2, USP17L5, FBXO11, RAD23B, UBE2V2, NED GO:0030163~protein catabolic process 1.81E-09 MKRN1, PPP2R5C, VPRBP, MYLIP, CDC16, ERLEC1, MKRN2, CUL3, 556 13588 1.87839 5.64E-06 1.41E-06 3.27E-06 ISG15, ATG7, PSENEN, LOC100046898, CDCA3, ANAPC1, ANAPC2, ANAPC5, SOCS3, ENC1, SOCS4,
    [Show full text]